Hagan Joseph P — SEC Form 4 filings
SEC reporting owner CIK 1465278. 7 Form 4 filings on record with FilingPulse; latest filed 2025-06-27.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-01-17 to 2025-06-27. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 50,000 shares, $54,260 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 3 legs across 2 filings — 141,634 shares, $177,854 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 19.
- Largest priced transaction: sale of 115,290 shares @ $1.26 ($145,634) in Regulus Therapeutics Inc., filed 2025-01-15.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Regulus Therapeutics Inc. (RGLS) | Chief Executive Officer, Director | 7 | 1 leg · 50,000 sh · $54,260 | 3 legs · 141,634 sh · $177,854 | 19 |
Form 4 filings — Hagan Joseph P
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-06-27 | 4 | Regulus Therapeutics Inc. (RGLS) | Disposition to issuer (D): 571,558 · Disposition to issuer (D): 6,500 (derivative) · Disposition to issuer (D): 1,000 (derivative) · Disposition to issuer (D): 100,000 (derivative) · Disposition to issuer (D): 90,000 (derivative) · Disposition to issuer (D): 160,000 (derivative) · +7 more | EDGAR |
| 2025-01-31 | 4 | Regulus Therapeutics Inc. (RGLS) | Purchase (P): 50,000 @ $1.09 · Grant/award (A): 1,350,000 (derivative) @ $0 | EDGAR |
| 2025-01-15 | 4 | Regulus Therapeutics Inc. (RGLS) | Sale (S): 115,290 @ $1.26 · Sale (S): 11,764 @ $1.26 | EDGAR |
| 2025-01-10 | 4 | Regulus Therapeutics Inc. (RGLS) | Grant/award (A): 218,750 @ $1.36 · Grant/award (A): 62,000 @ $1.30 | EDGAR |
| 2024-05-21 | 4 | Regulus Therapeutics Inc. (RGLS) | Grant/award (A): 990,000 (derivative) @ $0 | EDGAR |
| 2024-01-18 | 4 | Regulus Therapeutics Inc. (RGLS) | Sale (S): 14,580 @ $1.19 | EDGAR |
| 2024-01-17 | 4 | Regulus Therapeutics Inc. (RGLS) | Grant/award (A): 30,000 @ $0 · Grant/award (A): 249,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1465278 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →